Cite
MLA Citation
Jonathan Feld et al.. “Safety and Efficacy: Clinical Experience of Venetoclax in Combination With Hypomethylating Agents in Both Newly Diagnosed and Relapsed/Refractory Advanced Myeloid Malignancies.” HemaSphere, vol. 5, no. 4, 2021, pp. e549–. http://access.bl.uk/ark:/81055/vdc_100145478538.0x000016